Equivalence of Electronic vs Paper-based PHES in Diagnosing Hepatic Encephalopathy

StatusNot Yet Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to learn if an electronic version of the Psychometric Hepatic Encephalopathy Score (PHES) works as well as the standard paper version to diagnose minimal hepatic encephalopathy (MHE) in adults with liver cirrhosis. The main questions it aims to answer are: Do the total scores of the electronic and paper tests match for the same patient? Do both tests classify patients as having MHE or not in the same way? Researchers will compare the electronic PHES to the paper PHES to see if they produce equivalent results. Participants will: Be assigned by chance to one of two groups. Group A will take the paper test first, then the electronic test the next day. Group B will take the electronic test first, then the paper test the next day. Complete two cognitive tests (one paper-based and one electronic) on two separate days. Provide information about their medical history and complete routine blood tests as part of their standard care.
Trial Details
NCT Number NCT07874204
Lead Sponsor The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions
(from sponsor)
Liver Cirrhosis, Hepatic Encephalopathy (HE), Minimal Hepatic Encephalopathy
Related terms Hepatic Encephalopathy, Liver Cirrhosis
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov